BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Other Non-current Assets
Long-term assets not reported separately.
BillionToOne, Inc.NASDAQ: BLLN
Other Non-current Assets · Q2 FY2026 · quarter ended Jun 2026
Other non-current assets falls 31.3% from a year ago
Other non-current assets stood at $5.56M at the end of Q2 FY2026, down 31.3% from a year earlier and up 13.1% from the prior quarter.
Context
- Other non-current assets amounted to 0.8% of total assets at the end of Q2 FY2026, down 1.8 pp from a year earlier.
- Other non-current assets increased in 1 of the last 2 fiscal years.
What to watch
Whether other non-current assets keeps falling in the next quarterly balance sheet after a -31.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 4.99M USD
- Year-over-year change
- -7.4%
- 2-year CAGR
- +46.9%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.99M | -7.4% |
| FY2024 | 2024-12-31 | 5.39M | +133.0% |
| FY2023 | 2023-12-31 | 2.31M | — |
Other Non-current Assets vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 other non-current assets of $5.56M is the 7th highest of the 9 companies compared; the peer median is $11.82M.
- Its year-over-year change of -31.3% is the 8th highest of 9, against a peer median of +24.3%.
- Other non-current assets amounts to 0.8% of total assets for BLLN, versus a peer median of 0.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $140.77M | +558.6% | +31.5% | 7.5% | |
| Jun 2026 | $49.99M | +21.6% | +26.3% | 1.9% | |
| Mar 2026 | $17.15M | -47.6% | -19.7% | 1.5% | |
| Jun 2026 | $14.32M | +33.3% | +3.2% | 0.5% | |
| Jun 2026 | $9.31M | +27.1% | — | 0.7% | |
| Mar 2026 | $5.6M | -27.3% | -28.8% | 0.8% | |
BLLNBillionToOne, Inc. | Jun 2026 | $5.56M | -31.3% | — | 0.8% |
| Jun 2026 | $4.64M | +48.2% | -25.5% | 0.3% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $3.29M | -23.7% | -20.0% | 0.7% |
| Peer median (excluding BLLN) | $11.82M | +24.3% | -19.7% | 0.8% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.